Using Machine Learning to Predict Final HER2 Status in Invasive Breast Cancer Cases that are Equivocal (2+) by Immunohistochemistry

被引：0
|
作者：
Rasmussen, Sean [1 ,2 ]
Taylor, Valerie [2 ]
Surette, Alexi [3 ]
Barnes, Penny [1 ,2 ]
Bethune, Gillian [1 ,2 ]
机构：
[1] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Vitalite Hlth Network, Moncton, NB, Canada
来源：
MODERN PATHOLOGY | 2022年 / 35卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
164
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [31] Radiomics in 18F-FDG PET/CT predicts HER2 status in breast cancer with equivocal immunohistochemistry
    Malhaire, Caroline
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 170
  • [32] HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma
    Perron, Marjorie
    Wen, Hannah Y.
    Hanna, Matthew G.
    Brogi, Edi
    Ross, Dara S.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (08) : 979 - 987
  • [33] HER2 classification in breast cancer cells: A new explainable machine learning application for immunohistochemistry
    Cordova, Claudio
    Munoz, Roberto
    Olivares, Rodrigo
    Minonzio, Jean-Gabriel
    Lozano, Carlo
    Gonzalez, Paulina
    Marchant, Ivanny
    Gonzalez-Arriagada, Wilfredo
    Olivero, Pablo
    ONCOLOGY LETTERS, 2023, 25 (02)
  • [34] Tumoral heterogeneity and HER2 status in invasive breast cancer
    Asselah, J.
    Cottu, P.
    Vincent-Salomon, A.
    Dieras, V
    Mignot, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 568 - 568
  • [35] Status evaluation of HER2 in breast cancerology by immunohistochemistry
    Bekkouche, Z.
    Kahia-Tani, S.
    BULLETIN DU CANCER, 2007, 94 (06) : 571 - 571
  • [36] Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
    Ardor, Gokce Deniz
    Komforti, Miglena K.
    Hanna, Helena
    Ibanoglu, Onur
    Lochala, Abigail
    Nassar, Aziza
    BREAST JOURNAL, 2023, 2023
  • [37] Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases
    Carretero-Barrio, Irene
    Caniego-Casas, Tamara
    Rosas, Marta
    Concepcion Sanchez, Maria
    Martinez-Janez, Noelia
    Chiva, Miguel
    Sarrio, David
    Moreno-Bueno, Gema
    Palacios, Jose
    Perez-Mies, Belen
    CANCERS, 2023, 15 (06)
  • [38] HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence
    Criscitiello, Carmen
    Bagnardi, Vincenzo
    Viale, Giuseppe
    Disalvatore, Davide
    Rotmensz, Nicole
    Esposito, Angela
    Goldhirsch, Aron
    Curigliano, Giuseppe
    ANTICANCER RESEARCH, 2016, 36 (07) : 3537 - 3540
  • [39] HER2 Equivocal (Score=2+) Breast Carcinoma Cases Identified by Immunohistochemistry at a South African Hospital. What is the Impact of Fluorescent In Situ Hybridization Testing?
    Mohanlal, Reena Dhansukh
    Bouwer, Nikki
    Willem, Pascale
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2023, 31 (08) : 555 - 560
  • [40] In situ hybridization evaluation of HER2 2+(uncertain) breast carcinoma by immunohistochemistry
    Soares, I. C.
    Cirqueira, C. S.
    Ressio, R. A.
    Wakamatsu, A.
    Siqueira, S. A. C.
    Alves, V. A. F.
    HISTOPATHOLOGY, 2010, 57 : 39 - 39
12345